{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T04:03:28Z","timestamp":1793678608479,"version":"4.5.1"},"reference-count":24,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2016,12,14]],"date-time":"2016-12-14T00:00:00Z","timestamp":1481673600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014730","name":"Taipei City Government","doi-asserted-by":"crossref","award":["10201-62-046"],"award-info":[{"award-number":["10201-62-046"]}],"id":[{"id":"10.13039\/501100014730","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004700","name":"Taipei Medical University","doi-asserted-by":"publisher","award":["103-TMU-WFH-11"],"award-info":[{"award-number":["103-TMU-WFH-11"]}],"id":[{"id":"10.13039\/501100004700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology (Taiwan)","doi-asserted-by":"crossref","award":["MOST 103-2320-B-038-022-MY3"],"award-info":[{"award-number":["MOST 103-2320-B-038-022-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0168347","type":"journal-article","created":{"date-parts":[[2016,12,14]],"date-time":"2016-12-14T18:56:23Z","timestamp":1481741783000},"page":"e0168347","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Effects of Low Dose Metformin on Metabolic Traits in Clozapine-Treated Schizophrenia Patients: An Exploratory Twelve-Week Randomized, Double-Blind, Placebo-Controlled Study"],"prefix":"10.1371","volume":"11","author":[{"given":"Chih-Chiang","family":"Chiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mong-Liang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Chyi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Kuang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Ku","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Hsin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,12,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine","volume":"45","author":"J Kane","year":"1988","journal-title":"Arch Gen Psychiatry"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.schres.2007.11.033","article-title":"World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia","volume":"100","author":"R Tandon","year":"2008","journal-title":"Schizophr Res"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1176\/ajp.156.11.1686","article-title":"Antipsychotic-induced weight gain: a comprehensive research synthesis","volume":"156","author":"DB Allison","year":"1999","journal-title":"Am J Psychiatry"},{"issue":"Suppl 1","key":"ref4","first-page":"1","article-title":"Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review","volume":"19","author":"JW Newcomer","year":"2005","journal-title":"CNS Drugs"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1600-0447.2009.01401.x","article-title":"Prevalence of metabolic syndrome among patients with schizophrenia or schizoaffective disorder in Taiwan","volume":"120","author":"MC Huang","year":"2009","journal-title":"Acta Psychiatr Scand"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2008.10.011","article-title":"Results of phase 3 of the CATIE schizophrenia trial","volume":"107","author":"TS Stroup","year":"2009","journal-title":"Schizophr Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1053\/meta.2001.24192","article-title":"Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30","volume":"50","author":"CJ Glueck","year":"2001","journal-title":"Metabolism"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1038\/npp.2010.21","article-title":"Effectiveness of medications used to attenuate antipsychotic-related weight gain and metabolic abnormalities: a systematic review and meta-analysis","volume":"35","author":"L Maayan","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/schbul\/sbu030","article-title":"Pharmacological strategies to counteract antipsychotic-induced weight gain and metabolic adverse effects in schizophrenia: a systematic review and meta-analysis","volume":"40","author":"Y Mizuno","year":"2014","journal-title":"Schizophr Bull"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.schres.2009.05.007","article-title":"Extended release metformin for metabolic control assistance during prolonged clozapine administration: a 14 week, double-blind, parallel group, placebo-controlled study","volume":"113","author":"E Carrizo","year":"2009","journal-title":"Schizophr Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"364","DOI":"10.4103\/1735-1995.158262","article-title":"Double-blind, randomized, clinical trial of metformin as add-on treatment with clozapine in treatment of schizophrenia disorder","volume":"20","author":"P Hebrani","year":"2015","journal-title":"J Res Med Sci"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e424","DOI":"10.4088\/JCP.12m08186","article-title":"Effects of adjunctive metformin on metabolic traits in nondiabetic clozapine-treated patients with schizophrenia and the effect of metformin discontinuation on body weight: a 24-week, randomized, double-blind, placebo-controlled study","volume":"74","author":"CH Chen","year":"2013","journal-title":"J Clin Psychiatry"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"SR Kay","year":"1987","journal-title":"Schizophr Bull"},{"key":"ref14","first-page":"185","article-title":"Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial","volume":"299","author":"RR Wu","year":"2008","journal-title":"JAMA"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(09)61457-4","article-title":"10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study","volume":"374","author":"WC Knowler","year":"2009","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1176\/appi.ajp.2012.11091432","article-title":"Metformin for treatment of antipsychotic-induced amenorrhea and weight gain in women with first-episode schizophrenia: a double-blind, randomized, placebo-controlled study","volume":"169","author":"RR Wu","year":"2012","journal-title":"Am J Psychiatry"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e114112","DOI":"10.1371\/journal.pone.0114112","article-title":"Surrogate markers of visceral adiposity in young adults: waist circumference and body mass index are more accurate than waist hip ratio, model of adipose distribution and visceral adiposity index","volume":"9","author":"S Borruel","year":"2014","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e0156208","DOI":"10.1371\/journal.pone.0156208","article-title":"Metformin for Clozapine Associated Obesity: A Systematic Review and Meta-Analysis","volume":"11","author":"DJ Siskind","year":"2016","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1016\/S0149-2918(03)90089-0","article-title":"Metformin hydrochloride in the treatment of type 2 diabetes mellitus: a clinical review with a focus on dual therapy","volume":"25","author":"SM Setter","year":"2003","journal-title":"Clin Ther"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1176\/appi.ajp.2013.12010127","article-title":"Metformin for weight loss and metabolic control in overweight outpatients with schizophrenia and schizoaffective disorder","volume":"170","author":"LF Jarskog","year":"2013","journal-title":"Am J Psychiatry"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2796.2004.01328.x","article-title":"The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: a systematic review","volume":"256","author":"MG Wulffele","year":"2004","journal-title":"J Intern Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/schbul\/sbu030","article-title":"Pharmacological Strategies to Counteract Antipsychotic-Induced Weight Gain and Metabolic Adverse Effects in Schizophrenia: A Systematic Review and Meta-analysis","volume":"40","author":"Y Mizuno","year":"2014","journal-title":"Schizophr Bull"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/JCP.0000000000000392","article-title":"Metformin for Weight Gain and Metabolic Abnormalities Associated With Antipsychotic Treatment: Meta-Analysis of Randomized Placebo-Controlled Trials","volume":"35","author":"W Zheng","year":"2015","journal-title":"J Clin Psychopharmacol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/oxfordjournals.schbul.a033412","article-title":"How long to wait for a response to clozapine: a comparison of time course of response to clozapine and conventional antipsychotic medication in refractory schizophrenia","volume":"25","author":"R Rosenheck","year":"1999","journal-title":"Schizophr Bull"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0193315","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,2,16]],"date-time":"2018-02-16T00:00:00Z","timestamp":1518739200000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0168347","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T08:46:52Z","timestamp":1692607612000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0168347"}},"subtitle":[],"editor":[{"given":"F. Markus","family":"Leweke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,12,14]]},"references-count":24,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,12,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0168347","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.pone.0193315","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,14]]}}}